Priorix™

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline

Conditions

Chickenpox VaccinesHaemophilus Influenzae Type bMeaslesMumpsNeisseria MeningitidisRubellaVaricella

Phase 3

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

CompletedNCT00226499

GlaxoSmithKlineChickenpox Vaccines, Varicella

Start: 2005-09-01End: 2006-10-12Updated: 2019-09-23

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

CompletedNCT00326118

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2006-06-01End: 2007-11-06Updated: 2018-08-24

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

CompletedNCT00969436

GlaxoSmithKlineMeasles, Mumps, Rubella +1

Start: 2009-11-09End: 2011-02-21Updated: 2018-06-08

Related Papers

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children

Human Vaccines & Immunotherapeutics2021-08-268 citations

Clinically- versus serologically-identified varicella: A hidden infection burden. A ten-year follow-up from a randomized study in varicella-endemic countries

Human Vaccines & Immunotherapeutics2021-06-284 citations

Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.

2021-04-129 citations

Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants

Vaccine2021-03-1815 citations

Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up

Vaccine2019-07-2239 citations

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial.

2019-02-1129 citations

2355. Clinically vs. Serologically Identified Varicella: A Hidden Infection Burden. Lessons of 10-Year Follow-up in Varicella Endemic Countries

Open Forum Infectious Diseases2018-11-011 citations

One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.

2017-12-0718 citations

Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers.

2015-12-013 citations

Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial

BMJ Open2015-09-0119 citations

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.

2014-01-2969 citations

Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers.

2013-02-015 citations